CLOVIS ONCOLOGY, INC.

Inactive Instrument

Insiders Clovis Oncology, Inc.

Equities

CLVS.Q

US1894641000

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clovis Oncology Appoints Dr. Ronit Simantov to Its Board of Directors	21-07-12	CI
Clovis Oncology : Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine	21-06-28	BU
Clovis Oncology : Initial Clinical Experience Reported from FAP-2286 Named-Patient Use at ICPO Symposium	19-12-17	AQ
Clovis Oncology : Initial Clinical Experience Reported from FAP-2286 Named-Patient Use at ICPO Symposium	19-12-16	BU
Clovis Oncology, Inc. Announces Board Changes	19-06-06	CI
Clovis Oncology, Inc. Announces Resignation of Corwin Dale Hooks as Senior Vice President and Chief Commercial Officer	18-10-29	CI
Clovis Oncology, Inc. Announces Board Appointments	18-10-11	CI
Clovis Oncology, Inc. Announces Management Changes	16-04-01	CI
Clovis Oncology Announces Executive Changes	16-01-25	CI
Clovis Oncology, Inc. Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Announces Retirement of Erle T. Mast as Executive Vice President & Chief Financial Officer, Effective from March 31, 2016	15-11-05	CI
Clovis Oncology, Inc. Announces Resignation of Andrew Allen as Executive Vice President of Clinical & Pre-Clinical Development & Chief Medical Officer	15-08-12	CI
Clovis Oncology, Inc. Appoints Lindsey Rolfe as Chief Medical Officer and Executive Vice President of Clinical and Preclinical Development and Pharmacovigilance, Effective Early August 2015	15-06-22	CI
Clovis Oncology, Inc. Adds Ginger Graham and Keith Flaherty to its Board of Directors	13-06-13	CI
Clovis Oncology, Inc. Announces Resignation of Dr. John C. Reed from the Board of Directors	13-02-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer